These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 17967737)

  • 1. Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons.
    Mocchetti I; Bachis A; Nosheny RL; Tanda G
    Neurotox Res; 2007 Sep; 12(2):135-43. PubMed ID: 17967737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ; Batchelor PE; Howells DW
    Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.
    Ding YX; Xia Y; Jiao XY; Duan L; Yu J; Wang X; Chen LW
    Neurochem Res; 2011 Oct; 36(10):1759-66. PubMed ID: 21562748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein tyrosine phosphatase inhibition reduces degeneration of dopaminergic substantia nigra neurons and projections in 6-OHDA treated adult rats.
    Yang P; Dankowski A; Hagg T
    Eur J Neurosci; 2007 Mar; 25(5):1332-40. PubMed ID: 17425559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
    Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
    Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I
    J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease.
    Levivier M; Przedborski S; Bencsics C; Kang UJ
    J Neurosci; 1995 Dec; 15(12):7810-20. PubMed ID: 8613721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo.
    Nosheny RL; Ahmed F; Yakovlev A; Meyer EM; Ren K; Tessarollo L; Mocchetti I
    Eur J Neurosci; 2007 Apr; 25(8):2275-84. PubMed ID: 17445226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    Karunakaran S; Saeed U; Mishra M; Valli RK; Joshi SD; Meka DP; Seth P; Ravindranath V
    J Neurosci; 2008 Nov; 28(47):12500-9. PubMed ID: 19020042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism.
    Silva RM; Ries V; Oo TF; Yarygina O; Jackson-Lewis V; Ryu EJ; Lu PD; Marciniak SJ; Ron D; Przedborski S; Kholodilov N; Greene LA; Burke RE
    J Neurochem; 2005 Nov; 95(4):974-86. PubMed ID: 16135078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease.
    Tanriover G; Seval-Celik Y; Ozsoy O; Akkoyunlu G; Savcioglu F; Hacioglu G; Demir N; Agar A
    Folia Histochem Cytobiol; 2010 Sep; 48(3):434-41. PubMed ID: 21071351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.
    Howells DW; Porritt MJ; Wong JY; Batchelor PE; Kalnins R; Hughes AJ; Donnan GA
    Exp Neurol; 2000 Nov; 166(1):127-35. PubMed ID: 11031089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
    J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS; Brown EM; Miller MS; Carswell S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal degeneration of nigra-striatum dopaminergic neurons induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Li LH; Qin HZ; Wang JL; Wang J; Wang XL; Gao GD
    J Int Med Res; 2009; 37(2):455-63. PubMed ID: 19383240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease.
    Lin JG; Chen CJ; Yang HB; Chen YH; Hung SY
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease.
    Sun M; Kong L; Wang X; Lu XG; Gao Q; Geller AI
    Brain Res; 2005 Aug; 1052(2):119-29. PubMed ID: 16018990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.